[Form 4] Princeton Bancorp, Inc. Insider Trading Activity
Insider transaction by Martin Tuchman at Princeton Bancorp (BPRN). On 09/08/2025 Mr. Tuchman reported a purchase of 10,000 shares of Princeton Bancorp common stock at $33.00 per share. After the reported transactions he is shown as beneficially owning 639,141 shares indirectly as trustee of the Martin Tuchman Revocable Trust. The form also reports 123,838 shares disposed and 4,000 shares held indirectly by an IRA. The filing was signed by an attorney-in-fact on 09/09/2025.
- Purchase disclosed: Reporting person acquired 10,000 shares at $33.00, increasing reported holdings.
- Clear Section 16 disclosure: Transaction date, price, amounts, and ownership form are provided and form is signed.
- Significant disposition reported: 123,838 shares disposed are recorded on the form without explanation.
- No explanatory detail: The filing contains no narrative explaining the reason for the disposition or the context for the purchase.
Insights
TL;DR: Director and 10% owner acquired 10,000 shares at $33, increasing reported indirect holdings.
This Form 4 discloses a routine insider purchase by Martin Tuchman, who is identified as both a director and a greater-than-10% owner. The purchase of 10,000 shares at $33 is explicitly reported and the filing shows total indirect beneficial ownership of 639,141 shares as trustee of a revocable trust. The form also documents a disposition of 123,838 shares and 4,000 shares held indirectly via an IRA. For investors, the filing provides clear, contemporaneous detail on changes in insider ownership but contains no additional operational or financial metrics.
TL;DR: Disclosure is complete for Section 16 reporting: purchase, dispositions, and indirect holdings are documented.
The Form 4 appears to meet Section 16 disclosure requirements by reporting the transaction date, transaction code, price, amounts acquired and disposed, and forms of ownership (direct/indirect). It identifies Mr. Tuchman as a director and 10% owner and includes an attestation by an attorney-in-fact. The filing does not include explanatory footnotes beyond the transaction lines. There are no indications of amendments or 10b5-1 plan checkboxes checked in the provided text.